Sky Pharma Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Sky Pharma General Information
Description
Operator of a pharmaceutical company intended to engage in the research and development of drugs. The company aims to commercialize regenerative medicine using low molecular weight compounds to mass-produce drugs at a lower cost than biopharmaceuticals that use induced pluripotent stem cells, providing patients with affordable medicinal alternatives for diseases and injuries for which complete recovery is considered difficult.
Contact Information
Website
www.sky-pharma.netCorporate Office
- 1Floor, Higashi Nippon Real Estate Sendai First Building
- 6-1 Shimizu-koji, Wakabayashi-ku
- Sendai, Miyagi 984-0075
- Japan
Corporate Office
- 1Floor, Higashi Nippon Real Estate Sendai First Building
- 6-1 Shimizu-koji, Wakabayashi-ku
- Sendai, Miyagi 984-0075
- Japan
Sky Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-May-2025 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | 19-Jun-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 11-Oct-2021 | $286K | Completed | Generating Revenue | ||
| 1. Seed Round | 08-Nov-2020 | $286K | $286K | Completed | Generating Revenue |
Sky Pharma Patents
Sky Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026020249-A | Method for screening active pharmaceutical ingredient using function of cell or tissue as index | Pending | 31-Mar-2020 | ||
| AU-2021250052-A1 | Method for screening for, method for producing, and method for designing drug active ingredients | Inactive | 31-Mar-2020 | ||
| CA-3178684-A1 | Method for screening for, method for producing, and method for designing drug active ingredients | Pending | 31-Mar-2020 | ||
| EP-4129339-A1 | Method for screening for, method for producing, and method for designing drug active ingredients | Pending | 31-Mar-2020 | ||
| EP-4129339-A4 | Method for screening for, method for producing, and method for designing drug active ingredients | Pending | 31-Mar-2020 | G01N33/15 |
Sky Pharma Signals
Sky Pharma Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | |||
| Digital Search and Advertising | Corporation | Minority | ||
| Minato Mirai Capital | Venture Capital | Minority | ||
| Spurcle | Venture Capital | Minority |
Sky Pharma FAQs
-
When was Sky Pharma founded?
Sky Pharma was founded in 2019.
-
Where is Sky Pharma headquartered?
Sky Pharma is headquartered in Sendai, Japan.
-
What is the size of Sky Pharma?
Sky Pharma has 1 total employees.
-
What industry is Sky Pharma in?
Sky Pharma’s primary industry is Drug Discovery.
-
Is Sky Pharma a private or public company?
Sky Pharma is a Private company.
-
What is Sky Pharma’s current revenue?
The current revenue for Sky Pharma is .
-
How much funding has Sky Pharma raised over time?
Sky Pharma has raised $286K.
-
Who are Sky Pharma’s investors?
Plug and Play, Digital Search and Advertising, Minato Mirai Capital, and Spurcle have invested in Sky Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process